Literature DB >> 24689484

The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activity.

Shane M Wilkinson1, Hendra Gunosewoyo, Melissa L Barron, Aurelie Boucher, Michelle McDonnell, Peter Turner, Daniel E Morrison, Maxwell R Bennett, Iain S McGregor, Louis M Rendina, Michael Kassiou.   

Abstract

Relative to other polycyclic frameworks (1-3), a carborane cage (4 and Cs·5) exerts a significant biological effect as an inhibitor of the purinergic P2X7 receptor (P2X7R) which allows one to target depression in vivo and thus demonstrate, for the first time, that a carborane has the capacity to modify CNS activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24689484      PMCID: PMC4030799          DOI: 10.1021/cn500054n

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  17 in total

Review 1.  Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs.

Authors:  Jacques Joubert; Werner J Geldenhuys; Cornelis J Van der Schyf; Douglas W Oliver; Hendrik Gert Kruger; Thavendran Govender; Sarel F Malan
Journal:  ChemMedChem       Date:  2012-02-03       Impact factor: 3.466

Review 2.  The influence of drug-like concepts on decision-making in medicinal chemistry.

Authors:  Paul D Leeson; Brian Springthorpe
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

Review 3.  The ascent of mouse: advances in modelling human depression and anxiety.

Authors:  John F Cryan; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2005-09       Impact factor: 84.694

4.  Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity.

Authors:  T A Samad; K A Moore; A Sapirstein; S Billet; A Allchorne; S Poole; J V Bonventre; C J Woolf
Journal:  Nature       Date:  2001-03-22       Impact factor: 49.962

5.  Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding.

Authors:  A D Michel; L J Chambers; W C Clay; J P Condreay; D S Walter; I P Chessell
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

6.  Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.

Authors:  Ana M Basso; Natalie A Bratcher; Richard R Harris; Michael F Jarvis; Michael W Decker; Lynne E Rueter
Journal:  Behav Brain Res       Date:  2008-10-18       Impact factor: 3.332

7.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

Review 8.  Medicinal chemical properties of successful central nervous system drugs.

Authors:  Hassan Pajouhesh; George R Lenz
Journal:  NeuroRx       Date:  2005-10

9.  Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice.

Authors:  R D Porsolt; G Brossard; C Hautbois; S Roux
Journal:  Curr Protoc Neurosci       Date:  2001-05

10.  The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).

Authors:  A Surprenant; F Rassendren; E Kawashima; R A North; G Buell
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

View more
  22 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

Review 2.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

Review 3.  Advances in Drug Discovery and Development in Geriatric Psychiatry.

Authors:  Alexander C Conley; Paul A Newhouse
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

4.  Recent Advances in the Synthesis of Cyclobutanes by Olefin [2 + 2] Photocycloaddition Reactions.

Authors:  Saner Poplata; Andreas Tröster; You-Quan Zou; Thorsten Bach
Journal:  Chem Rev       Date:  2016-03-28       Impact factor: 60.622

5.  Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia.

Authors:  Anindya Bhattacharya; Brian Lord; Jan-Sebastian Grigoleit; Yingbo He; Ian Fraser; Shannon N Campbell; Natalie Taylor; Leah Aluisio; Jason C O'Connor; Mariusz Papp; Christa Chrovian; Nicholas Carruthers; Timothy W Lovenberg; Michael A Letavic
Journal:  Neuropsychopharmacology       Date:  2018-07-09       Impact factor: 7.853

6.  nido-Dicarbaborate Induces Potent and Selective Inhibition of Cyclooxygenase-2.

Authors:  Wilma Neumann; Shu Xu; Menyhárt B Sárosi; Matthias S Scholz; Brenda C Crews; Kebreab Ghebreselasie; Surajit Banerjee; Lawrence J Marnett; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2015-06-18       Impact factor: 3.466

Review 7.  Role of neuro-immunological factors in the pathophysiology of mood disorders.

Authors:  Anindya Bhattacharya; Noel C Derecki; Timothy W Lovenberg; Wayne C Drevets
Journal:  Psychopharmacology (Berl)       Date:  2016-01-23       Impact factor: 4.530

8.  The elements of life and medicines.

Authors:  Prinessa Chellan; Peter J Sadler
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2015-03-13       Impact factor: 4.226

9.  Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue.

Authors:  Stefan Saretz; Gabriele Basset; Liridona Useini; Markus Laube; Jens Pietzsch; Dijana Drača; Danijela Maksimović-Ivanić; Johannes Trambauer; Harald Steiner; Evamarie Hey-Hawkins
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

10.  Ruthenacarborane and Quinoline: A Promising Combination for the Treatment of Brain Tumors.

Authors:  Dijana Drača; Milan Marković; Marta Gozzi; Sanja Mijatović; Danijela Maksimović-Ivanić; Evamarie Hey-Hawkins
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.